NCT00560261 Clinical Trial Information | SourceSolution's Biotech, Pharma, CMO, CRO Directory

Evaluation of the Lung Capillary Blood Volume in Children With Sickle Cell Disease


Sponsors: Assistance Publique - Hôpitaux de Paris	Phases: Phase III
Indications	Acronym: VOLCADREP
Sickle Cell Disease
Age Groups: Child Adult	Gender: Both
Names: Other: NO-CO inhalation and expiration Other: NO-CO inhalation and expiration	Enrollment: 240

Additional information about NCT00560261.